Licenced doses of approved COVID-19 vaccines may not be optimal: A review of the early-phase, dose-finding trials. (2023)

First Author: Dunn DT

Attributed to: Respiratory infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2023.06.037

PubMed Identifier: 37355453

Publication URI: http://europepmc.org/abstract/MED/37355453

Type: Journal Article/Review

Volume: 41

Parent Publication: Vaccine

Issue: 31

ISSN: 0264-410X